445218-34-8

CNS-11 is a blood-brain barrier permeable tau fibril-degrading compound. CNS-11 reduces α-synuclein. CNS-11 can be used in Alzheimer's and Parkinson's disease research[1][2].

Brain tissue penetrant alpha-synuclein ligand th at potently disaggregate alpha-synuclein fibrils in vitro and in vivo models.



CNS-11 is brain tissue penetrant alpha-synuclein ligand th at potently disaggregate alpha-synuclein fibrils in vitro and in vivo models. CNS-11 inhibits intracellular seeding of a-synuclein fibrils in biosensor cells—HEK293T cells. C-11 reduces number of a-synuclein aggregates in C. elegans model.

[1] Paul M Seidler, et al. Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived tau fibrils in vitro. Nat Commun. 2022 Sep 16;13(1):5451. DOI:10.1038/s41467-022-32951-4
[2] Murray KA, et al. Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils. Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2217835120. DOI:10.1073/pnas.2217835120